Godavari Biorefineries is currently trading at Rs. 287.70, up by 32.10 points or 12.56% from its previous closing of Rs. 255.60 on the BSE.
The scrip opened at Rs. 254.05 and has touched a high and low of Rs. 295.25 and Rs. 250.30 respectively. So far 164579 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 352.00 on 24-Jul-2025 and a 52 week low of Rs. 145.20 on 28-Mar-2025.
Last one week high and low of the scrip stood at Rs. 295.25 and Rs. 243.70 respectively. The current market cap of the company is Rs. 1466.45 crore.
The promoters holding in the company stood at 63.31%, while Institutions and Non-Institutions held 12.02% and 24.67% respectively.
Godavari Biorefineries has entered into partnership with Synthomer to develop bio based alternatives to existing fossil based monomers. With growing customer demand for more sustainable alternatives, this partnership strengthens the company’s commitment to innovation and reinforces its focus on delivering customer-centric, lower carbon solutions.
Through this partnership, Synthomer is commercialising bio-based butyl acrylate using bio-based butanol produced by the company, helping to accelerate the industry’s transition to more sustainable raw materials.
Godavari Biorefineries is one of the manufacturers of ethanol-based chemicals in India. Its diversified product portfolio comprises of bio-based chemicals, sugar, different grades of ethanol and power.
| Company Name | CMP |
|---|---|
| Shree Renuka Sugar | 22.16 |
| Bajaj Hindusthan Sug | 19.31 |
| Triveni Engg. & Inds | 372.10 |
| Balrampur Chini Mill | 531.35 |
| Dalmia Bharat Sugar | 331.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: